9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.

      European Journal of Clinical Pharmacology

      Adult, Aged, Antipsychotic Agents, blood, pharmacokinetics, therapeutic use, Benzodiazepines, Chromatography, High Pressure Liquid, Clozapine, Cytochrome P-450 CYP1A2, metabolism, Dose-Response Relationship, Drug, Drug Interactions, Drug Monitoring, methods, Female, Humans, Inpatients, statistics & numerical data, Male, Mass Spectrometry, Metabolic Clearance Rate, Middle Aged, Nursing Homes, Schizophrenia, drug therapy, Smoking

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cigarette smoking has been shown in several studies to induce the metabolism of the cytochrome P4501A2 (CYP1A2) substrates clozapine and olanzapine. The aim of the present study was to investigate the dose-dependent effect of cigarette smoking on serum concentrations of these drugs in a naturalistic setting. In 73 schizophrenic patients recruited from psychiatric nursing homes, patient characteristics, smoking habits, drug dosing and serum concentrations of clozapine (n=33) and olanzapine (n=40) were registered. Concentration to dose (C/D) ratios of clozapine and olanzapine in non-smokers and subgroups of smokers were compared. Fifty-nine patients (80%) were smokers and these were stratified into the following groups according to smoking habits: 1-6 (n=0), 7-12 (n=13), 13-19 (n=18) and >or=20 (n=28) cigarettes daily. While the mean ratio was twice as high in non-smokers compared to smokers for both drugs (p<0.01), the C/D ratios of clozapine and olanzapine were not significantly different between the subgroups of smokers (p >0.15). Absolute serum concentrations were also higher in non-smokers compared to smokers: 50% for clozapine (p=0.058) and 67% for olanzapine (p<0.01). A daily consumption of 7-12 cigarettes is probably sufficient for maximum induction of clozapine and olanzapine metabolism. A 50% lower starting dose of both drugs in non-smokers seems rational to avoid side effects.

          Related collections

          Author and article information

          Journal
          17089108
          10.1007/s00228-006-0209-9

          Comments

          Comment on this article